SCHEMBL4328100

SCHEMBL4328100

CC(C)O[C@@H](Cc1cccc(CNC(=O)OCCc2cccc(Cl)c2)c1)C(=O)O

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PPARG P37231 2/20 0.44
PPARA Q07869 2/20 0.44
PPARD Q03181 1/20 0.44
SLC2A1 P11166 1/20 0.44
MASP2 O00187 1/20 0.41
RXFP1 Q9HBX9 1/20 0.41
APEX1 P27695 1/20 0.41
PADI3 Q9ULW8 1/20 0.40
PADI4 Q9UM07 1/20 0.40
TSHR P16473 2/20 0.40
MAPK1 P28482 2/20 0.40
HTT P42858 2/20 0.40
MEN1 O00255 1/20 0.40
CYP1A2 P05177 1/20 0.40
MAPT P10636 1/20 0.40
CYP2C9 P11712 1/20 0.40
CYP2C19 P33261 1/20 0.40
KMT2A Q03164 1/20 0.40
SMN1; SMN2 Q16637 1/20 0.40
LMNA P02545 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4328098 1.00 PPARG (0.44) PPARGPPARAPPARDSLC2A1MASP2
SCHEMBL4333057 0.92 PPARG (0.42) PPARGPPARAPPARDTSHRSMN1; SMN2
SCHEMBL4333055 0.92 PPARG (0.42) PPARGPPARAPPARDTSHRSMN1; SMN2
SCHEMBL4339256 0.90 PPARG (0.46) PPARGPPARAPPARDSLC2A1MASP2
SCHEMBL4339331 0.89 ATM (0.46) PPARGPPARAPPARDPADI3PADI4
SCHEMBL4339328 0.89 ATM (0.46) PPARGPPARAPPARDPADI3PADI4
SCHEMBL4331720 0.86 MAPK1 (0.52) PPARGPPARAPPARDTSHRMAPK1
SCHEMBL4339339 0.86 PPARG (0.41) PPARGPPARAPPARDPADI3PADI4
SCHEMBL4339342 0.86 PPARG (0.41) PPARGPPARAPPARDPADI3PADI4
SCHEMBL4339657 0.86 PLAU (0.39) PPARGPPARA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7544835-B2 Carboxylic acid derivative and salt thereof EISAI R&D MANAGEMENT CO., LTD. (JP) 2009-06-09 US disclosed
US-7544835-B2 Carboxylic acid derivative and salt thereof EISAI R&D MANAGEMENT CO., LTD. (JP) 2009-06-09 US disclosed
US-7544835-B2 Carboxylic acid derivative and salt thereof EISAI R&D MANAGEMENT CO., LTD. (JP) 2009-06-09 US disclosed
US-20040102634-A1 Carboxylic acid derivative and salt thereof EISAI R&D MANAGEMENT CO., LTD. (JP) 2004-05-27 US disclosed
EP-1380562-A1 CARBOXYLIC ACID DERIVATIVE AND SALT THEREOF Eisai Co., Ltd. (JP) 2004-01-14 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040102634-A1 Carboxylic acid derivative and salt thereof GPR119, IRS1, SLC5A1 PPARG 379/4885PPARA 339/4885PPARD 753/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.